1. Home
  2. SOLS vs GH Comparison

SOLS vs GH Comparison

Compare SOLS & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SOLS

Solstice Advanced Materials Inc.

N/A

Current Price

$77.51

Market Cap

11.9B

Sector

Industrials

ML Signal

N/A

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$93.11

Market Cap

13.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOLS
GH
Founded
2025
2011
Country
United States
United States
Employees
4400
N/A
Industry
Aerospace
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.9B
13.3B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
SOLS
GH
Price
$77.51
$93.11
Analyst Decision
Buy
Strong Buy
Analyst Count
4
19
Target Price
$72.75
$120.05
AVG Volume (30 Days)
1.9M
1.7M
Earning Date
05-06-2026
04-29-2026
Dividend Yield
0.38%
N/A
EPS Growth
N/A
6.74
EPS
N/A
N/A
Revenue
N/A
$982,021,000.00
Revenue This Year
$6.46
$33.30
Revenue Next Year
$5.46
$28.19
P/E Ratio
$54.31
N/A
Revenue Growth
N/A
32.88
52 Week Low
$40.43
$36.36
52 Week High
$84.44
$120.74

Technical Indicators

Market Signals
Indicator
SOLS
GH
Relative Strength Index (RSI) 56.46 52.72
Support Level $69.12 $89.32
Resistance Level $83.07 $103.16
Average True Range (ATR) 3.39 4.50
MACD 0.31 1.32
Stochastic Oscillator 80.78 75.20

Price Performance

Historical Comparison
SOLS
GH

About SOLS Solstice Advanced Materials Inc.

Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell. It sells chemicals and materials to a wide range of end markets. Its largest product category is refrigerants used in heating, ventilation and air conditioning systems, and autos, where Solstice sells low global warming potential refrigerants. The company also sells materials used for building and construction, semiconductor production, healthcare packaging, and defense. Additionally, Solstice runs the only US uranium conversion business currently in operation.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: